
Edenton Pharmaceuticals Private Limited
About Edenton Pharmaceuticals Private Limited
Data last updated:
Edenton Pharmaceuticals Private Limited is a private limited company based in Vasai, Maharashtra, India. It was incorporated on 07 August 2024.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U46497MH2024PTC430291.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mansa Dhananjay Pandey and Dhananjay Kumar Pandey.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vasai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹93,388. For the same year it recorded a net loss of ₹65,118 (net margin -69.7%) and EBITDA of -₹65,000 (EBITDA margin -69.6%).
Company details
Contact details
Edenton Pharmaceuticals Private Limited's registered office is in Vasai, Maharashtra.
- Registered AddressShop No. 03 Sai Palace, Bldg No.2, Vasai, Maharashtra, India – 401208
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Edenton Pharmaceuticals Private Limited
FY 2025 filings availableEdenton Pharmaceuticals Private Limited reported revenue of ₹93,388 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹65,000 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹65,118 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -69.6% |
| Net Profit Margin | -69.7% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Edenton Pharmaceuticals Private Limited, buy the company report.
Board of directors of Edenton Pharmaceuticals Private Limited
Edenton Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mansa Dhananjay Pandey | Director | 07 Aug 2024 | 2 Years 3 Months | Current |
| Dhananjay Kumar Pandey | Director | 07 Aug 2024 | 2 Years 3 Months | Current |
Peer comparison
Edenton Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gupixi Pharmaceuticals Private Limited | ₹94,790 (FY 2025) | -21.0% | Meerut, Uttar Pradesh, India | |||
| Lorda Pharmaceuticals Private Limited | ₹94,569 (FY 2016) | -33.0% | Mumbai, Maharashtra, India | |||
| Strigine Pharmaceuticals Private Limited | ₹94,422 (FY 2023) | 8.0% | Hyderabad, Telangana, India | |||
| Hazor Pharmaceuticals Private Limited | ₹93,979 (FY 2025) | -94.0% | Allahabad, Uttar Pradesh, India | |||
| Loriox India Pharmaceuticals Private Limited | ₹93,884 (FY 2024) | Hyderabad, Telangana, India | ||||
| Edenton Pharmaceuticals Private Limitedthis company | ₹93,388 (FY 2025) | -₹65,118 | -69.7% | Vasai, Maharashtra, India | ||
| Banny Pharmaceuticals Private Limited | ₹93,240 (FY 2021) | Hyderabad, Telangana, India | ||||
| Sanlagan Pharmaceuticals Private Limited | ₹92,852 (FY 2025) | Pune, Maharashtra, India | ||||
| Biocherry Pharmaceuticals Private Limited | ₹92,366 (FY 2023) | Ranchi, Jharkhand, India | ||||
| Ementis Pharmaceuticals Private Limited | ₹92,006 (FY 2023) | Pune, Maharashtra, India | ||||
| Herabdayal Pharmaceuticals Private Limited | ₹92,000 (FY 2024) | Delhi, India |
To see the full peer comparison of Edenton Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Edenton Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Edenton Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Edenton Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Edenton Pharmaceuticals Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Dhananjay Kumar Pandey was appointed as Director on 07 Aug 2024.
Frequently asked questions
Edenton Pharmaceuticals is an active private limited company based in Vasai, Maharashtra, India. It was incorporated on 07 August 2024 (2+ years old) and is registered under CIN U46497MH2024PTC430291.
Edenton Pharmaceuticals has 2 current directors:
- Mansa Dhananjay Pandey - Director
- Dhananjay Kumar Pandey - Director
The latest financial statements of Edenton Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Edenton Pharmaceuticals is U46497MH2024PTC430291. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Edenton Pharmaceuticals was incorporated on 07 August 2024, making it 2+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Edenton Pharmaceuticals by revenue are Gupixi Pharmaceuticals Private Limited, Lorda Pharmaceuticals Private Limited, Strigine Pharmaceuticals Private Limited, Hazor Pharmaceuticals Private Limited, Loriox India Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Dhananjay Kumar Pandey was appointed as Director on 07 Aug 2024. Mansa Dhananjay Pandey was appointed as Director on 07 Aug 2024.
The registered office of Edenton Pharmaceuticals is at Shop No. 03 Sai Palace, Bldg No.2, Vasai, Maharashtra, India – 401208.
Edenton Pharmaceuticals can be reached at its registered office: Shop No. 03 Sai Palace, Bldg No.2, Vasai, Maharashtra, India – 401208.
Edenton Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.

